Clinical Trial

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-09-19; most recent amendment 2026-02-28.
Status change: Not Yet Recruiting → Recruiting 2024-10-01
Trial Details
NCT Number NCT06605378
Lead Sponsor Ensoma
Conditions Chronic Granulomatous Disease (CGD)
Enrollment 60 participants
Start Date 2024-11-18
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-03